Pulmatrix, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pulmatrix, Inc. (NASDAQ: PULM) on December 18, 2025, covering events occurring on December 17, 2025. The filing relates to the ongoing Agreement and Plan of Merger and Reorganization with Cullgen Inc., originally dated November 13, 2024, and amended on April 7, 2025.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance event regarding the merger agreement.
Material Changes
On December 17, 2025, Pulmatrix, Inc., Cullgen Inc., and PCL Merger Sub, Inc. entered into a mutual Waiver Agreement. The key material change is the mutual waiver of compliance with Section 5.4 of the Merger Agreement, which imposes restrictions on the parties during the Pre-Closing Period. Except for this specific waiver, the Merger Agreement remains in full force and effect without other amendments.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, outlook, or management commentary on future performance. The primary disclosure is the execution of the Waiver Agreement to facilitate the merger process. No new risks or contingencies were explicitly detailed beyond the modification of the existing merger terms.
Investor Verification Checklist
- Verify the specific terms of the waived Section 5.4 restrictions in the original Merger Agreement.
- Review the press release dated December 18, 2025 (Exhibit 99.1) for additional context on the waiver.
- Confirm the status of the merger closing conditions and timeline following this waiver.
- Monitor for subsequent filings regarding the finalization of the merger with Cullgen Inc.